ARWR
Arrowhead Pharmaceuticals, Inc.
$71.91
-2.20 (-2.97%)
At close · Jul 14
Market Cap
$10.13B
Shares
140,857,021
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$829.45M
+23258.2%
FY2025
Net Income
-$1.63M
+99.7%
FY2025
Operating Margin
11.86%
+16938.9pp
FY2025
Diluted EPS
-$0.01
+99.8%
FY2025
Operating Cash Flow
$179.55M
+138.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $622.01M | $829.45M | $3.55M | $240.74M | $243.23M | $138.29M | $87.99M | $168.8M | $16.14M | $31.41M | $158.33K | $382K | $175K | $290.27K | $146.88K | $296.14K | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | $645.49K | -$97.91K | $35.97K | $86.53K | -$22.78K | — | — | — | — | — | — | — | |
| $687.51M | $607.16M | $505.87M | $353.19M | $297.31M | $206.34M | $128.88M | $81.05M | $52.97M | $50.9M | $62.12M | $47.27M | $23.14M | $8.71M | $5.39M | $3.28M | $529.6K | — | — | — | — | — | — | — | |
| $143.05M | $123.94M | $98.76M | $92.55M | $124.43M | $80.98M | $52.28M | $26.56M | $19.11M | $17.5M | $23.59M | $7.93M | $5.89M | $3.49M | $6.44M | $3.8M | $2.49M | — | — | — | — | — | — | — | |
| $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.71M | $1.05M | $54.65K | $236.01K | $293.96K | $241.81K | $241.81K | — | — | — | — | — | — | — | |
| $23.7M | $22.2M | $16.9M | $10.7M | $8.7M | $6.6M | $4.2M | $2.7M | $3M | $2.99M | $3.26M | $2.34M | $1.35M | $1.75M | $1.75M | $267.98K | $277.65K | — | — | — | — | — | — | — | |
| $843.9M | $731.1M | $604.63M | $445.74M | $421.74M | $287.32M | $181.15M | $107.61M | $72.08M | $68.4M | $81.9M | $96.36M | $53.45M | $24.88M | $21.24M | $10.13M | $5.83M | — | — | — | — | — | — | — | |
| -$221.9M | $98.35M | -$601.08M | -$205M | -$178.51M | -$149.04M | -$93.16M | $61.19M | -$55.94M | -$37M | -$81.74M | -$95.97M | -$53.28M | -$24.59M | -$21.09M | -$9.83M | -$5.83M | — | — | — | — | — | — | — | |
| — | 11.86% | -16927.06% | -85.16% | -73.39% | -107.77% | -105.87% | 36.25% | -346.52% | -117.79% | -51627.09% | -25124.08% | -30443.59% | -8471.29% | -14358.61% | -3319.48% | — | — | — | — | — | — | — | — | |
| -$198.2M | $120.55M | -$584.18M | -$194.3M | -$169.81M | -$142.44M | -$88.96M | $63.89M | -$52.94M | -$34.01M | -$78.48M | -$93.64M | -$51.93M | -$22.84M | -$19.34M | -$9.56M | -$5.56M | — | — | — | — | — | — | — | |
| $92.43M | $89.36M | $32.35M | $18.33M | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$30.37M | -$46.81M | -$11.38M | -$1.49M | $5.8M | $8.19M | $8.61M | $6.96M | $1.49M | $2.62M | $22.12K | $4.04M | -$5.44M | -$7.11M | -$1.02M | $1.05M | $1.52M | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | -$78.87K | -$641.14K | -$240.15K | -$163.18K | -$219.54K | — | — | — | — | — | — | — | |
| — | — | — | $0 | -$4.43M | $1.71M | $20K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$252.26M | $51.53M | -$612.46M | -$206.49M | -$172.71M | -$140.85M | -$84.55M | $68.15M | -$54.45M | -$34.38M | -$81.72M | -$91.94M | -$58.72M | -$31.7M | -$22.11M | -$8.79M | -$4.31M | — | — | — | — | — | — | — | |
| $19.6M | $21.42M | -$2.77M | $2.78M | $3.79M | $2000 | $2000 | $174K | $2400 | $2400 | $2400 | $2400 | $5300 | — | — | — | — | — | — | — | — | — | — | — | |
| -$298.78M | -$1.63M | -$599.49M | -$205.28M | -$176.06M | -$140.85M | -$84.55M | $67.98M | -$54.45M | -$34.38M | -$81.72M | -$91.94M | -$58.63M | -$31.14M | -$21.13M | -$3.13M | -$5.77M | -$19.31M | -$27.24M | -$30.71M | -$19.96M | -$6.73M | -$751.26K | -$95.24K | |
| — | -0.2% | -16882.37% | -85.27% | -72.39% | -101.85% | -96.09% | 40.27% | -337.32% | -109.46% | -51614.64% | -24068.29% | -33502.97% | -10729.22% | -14383.61% | -1056.56% | — | — | — | — | — | — | — | — | |
| $29.05M | $31.75M | -$10.2M | -$4M | -$431K | $0 | $0 | — | — | — | — | — | -$95.22K | -$560.14K | -$984.8K | -$363.51K | -$1.18M | — | — | — | — | — | — | — | |
| — | — | — | — | — | -$140.94M | -$84.14M | $67.61M | -$54.51M | -$34.35M | -$81.58M | -$92.08M | -$58.63M | -$31.14M | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$0.01 | -$5.00 | -$1.92 | -$1.67 | -$1.36 | -$0.84 | $0.72 | -$0.65 | -$0.47 | — | — | — | — | -$1.90 | -$0.44 | -$0.90 | — | — | — | — | — | — | — |
| USD/shares | — | -$0.01 | -$5.00 | -$1.92 | -$1.67 | -$1.36 | -$0.84 | $0.69 | -$0.65 | -$0.47 | — | — | — | — | — | -$0.40 | -$0.90 | — | — | — | — | — | — | — |
| shares | — | 133.76M | 119.78M | 106.75M | 105.43M | 103.75M | 100.72M | 93.86M | 83.64M | 73.9M | 61.05M | 57.36M | 46.93M | 24M | 11.13M | 7.18M | 6.43M | — | — | — | — | — | — | — |
| shares | — | 133.76M | 119.78M | 106.75M | 105.43M | 103.75M | 100.72M | 98.61M | 83.64M | 73.9M | 61.05M | 57.36M | 46.93M | 24M | 11.13M | 7.83M | 6.43M | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.34×
EV/EBIT
—
Biotechnology median 25.45×
P/E (TTM)
—
Biotechnology median 7.56×
Valuation over time computed as of each quarter's filing date
Key facts
CIK
879407
CUSIP
04280A100
13F (30d)
32 filings
27 filers
Visit website
Investor relations